Recombinant Enolase of Trypanosoma cruzi as a Novel Vaccine Candidate against Chagas Disease in a Mouse Model of Acute Infection

Chagas disease

(2018) José A Pérez-Molina et al.   LANCET

Immunization with Brucella VirB Proteins Reduces Organ Colonization in Mice through a Th1-Type Immune Response and Elicits a Similar Immune Response in Dogs

(2014) Cora N. Pollak et al.   Clinical and Vaccine Immunology

In silico approach for the identification of immunological properties of enolase from Trypanosoma cruzi and its possible usefulness as vaccine in Chagas disease

(2014) Alejandro Carabarín-Lima et al.   PARASITOLOGY RESEARCH

Nuclear Glycolytic Enzyme Enolase of Toxoplasma gondii Functions as a Transcriptional Regulator

(2014) Thomas Mouveaux et al.   PLoS One

A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas disease

(2014) Carylinda Serna et al.   VACCINE

Chagas disease (American trypanosomiasis) in Mexico: An update

(2013) Alejandro Carabarin-Lima et al.   ACTA TROPICA

A DNA Vaccine Encoding for TcSSP4 Induces Protection against Acute and Chronic Infection in Experimental Chagas Disease

(2012) Minerva Arce-Fonseca et al.   International Journal of Biological Sciences

Ascaris suum enolase is a potential vaccine candidate against ascariasis

(2012) Ning Chen et al.   VACCINE

Trypanosoma cruzi and Chagas' Disease in the United States

(2011) C. Bern et al.   CLINICAL MICROBIOLOGY REVIEWS

Antitrypanosomal Therapy for Chronic Chagas' Disease

(2011) Caryn Bern   NEW ENGLAND JOURNAL OF MEDICINE

Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice

(2011) Wen qing Li et al.   VACCINE

Chagas disease and stroke

(2010) Francisco Javier Carod-Artal et al.   LANCET NEUROLOGY

Reverse vaccinology approach identify an Echinococcus granulosus tegumental membrane protein enolase as vaccine candidate

(2010) Wenjia Gan et al.   PARASITOLOGY RESEARCH

Prevalence, Clinical Staging and Risk for Blood-Borne Transmission of Chagas Disease among Latin American Migrants in Geneva, Switzerland

(2010) Yves Jackson et al.   PLoS Neglected Tropical Diseases

Prevalence and Vertical Transmission ofTrypanosoma cruziInfection among Pregnant Latin American Women Attending 2 Maternity Clinics in Barcelona, Spain

(2009) José Muñoz et al.   CLINICAL INFECTIOUS DISEASES

Immunization with SsEno fails to protect mice against challenge withStreptococcus suisserotype 2

(2009) Miriam Esgleas et al.   FEMS MICROBIOLOGY LETTERS

Surface-Expressed Enolase Contributes to the Pathogenesis of Clinical Isolate SSU of Aeromonas hydrophila

(2009) J. Sha et al.   JOURNAL OF BACTERIOLOGY

Streptococcus suisEnolase Functions as a Protective Antigen Displayed on the Bacterial Cell Surface

(2009) Youjun Feng et al.   JOURNAL OF INFECTIOUS DISEASES

Identification and characterization of a novel protective antigen, Enolase of Streptococcus suis serotype 2

(2009) Anding Zhang et al.   VACCINE

Identification of novel vaccine candidates for Chagas’ disease by immunization with sequential fractions of a trypomastigote cDNA expression library

(2009) Valeria Tekiel et al.   VACCINE

Novel Protective Antigens Expressed by Trypanosoma cruzi Amastigotes Provide Immunity to Mice Highly Susceptible to Chagas' Disease

(2008) E. L. V. Silveira et al.   Clinical and Vaccine Immunology

Immunization with Recombinant Brucella Species Outer Membrane Protein Omp16 or Omp19 in Adjuvant Induces Specific CD4+ and CD8+ T Cells as Well as Systemic and Oral Protection against Brucella abortus Infection

(2008) K. A. Pasquevich et al.   INFECTION AND IMMUNITY

Elicitation of specific, Th1-biased immune response precludes skeletal muscle damage in cruzipain-vaccinated mice

(2007) F.M. Frank et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY